ATP13A2 and Parkinson disease: These observations were subsequently confirmed in a mouse PD model where zinc was shown to increase α-synuclein aggregation; overexpression of ATP13A2 neutralized the effect of zinc thus alleviating α-synuclein pathology whereas its knockout significantly aggravated fibrillation (Gao et al., 2022).